leisure time -WSS

leisure time

author：focus 2025-09-28 01:35:14 - browse：548

At some point this summer, the drugmaker Novo Nordisk will release results from a closely watched study that, if successful, could further uncork demand for new obesity medications, streamline insurance coverage for the therapies, and demonstrate long-lasting health benefits.

The Select trial, as the study is called, is the first large, randomized trial to test whether long-term treatment with a weight loss drug can meaningfully improve patients’ cardiovascular health. Novo is testing Wegovy, a weekly injection also sold under the brand name Ozempic for type 2 diabetes, against placebo in the five-year study.

The implications are massive, and not just for Novo. Wegovy is part of a class of medicines that target a hormone called GLP-1, which curbs patients’ appetites. Those drugs have demonstrated an ability to help people lose dramatic amounts of weight in clinical trials, but payers, including Medicare, have been slow to reimburse for them without definitive data on their long-term health benefits.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Choosing scientific sides in the fight against Alzheimer's

explore

WSS

Biden praises World Series champion Astros for impact off the field during White House celebration

FTX founder Sam Bankman

Heart disease in astronauts blamed on cosmic radiation

Hospitals use virtual reality to design more inclusive rooms for kids

Florida officials tell state schools to teach AP Psychology 'in its entirety'

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

entertainment

leisure time

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Heart disease in astronauts blamed on cosmic radiation

New air purifier tech could be key to improving indoor air quality

Physicians aren't 'burning out.' They're suffering from moral injury

Novavax promises a turnaround & Lilly roils the obesity market

FTX founder Sam Bankman

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Former Georgia lieutenant governor says he received grand jury subpoena

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Heart disease in astronauts blamed on cosmic radiation

hotspot

Group behind ProMed defends move to subscription

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

Group behind ProMed defends move to subscription

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

FDA approves Sage Therapeutics’ rapid

Former Georgia lieutenant governor says he received grand jury subpoena

knowledge

explore

hotspot

Wikipedia